News

Finally, the market wakes up to resistance

Novartis’s move to take over UK biotech NeuTec Pharma at a large premium highlights how the so-called “superbugs” have reinvigorated pharma’s interest in antibiotics.

EU research budget approved

Funds should start flowing at the start of 2007 in the €50 billion Framework Programme 7 after the European Parliament approved the budget.